Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer

This publication has 37 references indexed in Scilit:

• Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen
  The Journal of Steroid Biochemistry and Molecular Biology, 1982
• Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
  New England Journal of Medicine, 1981
• Structural derivatives of tamoxifen and oestradiol 3-methyl ether as potential alkylating antioestrogens
  Published by Elsevier ,1981
• Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model
  Published by Elsevier ,1980
• Seco-oestradiols and some non-steroidal oestrogens: Structural correlates of oestrogenic action
  Journal of Steroid Biochemistry, 1979
• The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions
  Published by Elsevier ,1979
• Tamoxifen in advanced breast cancer
  Cancer Treatment Reviews, 1978
• Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols
  International Journal of Cancer, 1976
• Estrogen receptors interaction with Estracyt and degradation products, a biochemical study on a potential agent in the treatment of breast cancer
  European Journal of Drug Metabolism and Pharmacokinetics, 1976
• Essai clinique du phénol bis (2-chloroéthyl) carbamate d'oestradiol dans le cancer mammaire en phase avancée
  European Journal of Cancer (1965), 1969